Global Human Gene Therapy Market Research Report 2026(Status and Outlook)
Gene therapy is a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person"s genetic makeup instead of using drugs or surgery.Advances in gene therapy technology, increasing understanding of genetics, and the potential for addressing previously untreatable diseases contribute to the growth of the Human Gene Therapy market.
The global Human Gene Therapy market size was estimated at USD 5677.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Gene Therapy market.
Global Human Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics
Market Segmentation (by Type)
Non-viral Vectors
Viral Vectors
Market Segmentation (by Application)
Neurological Diseases
Cancer
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Gene Therapy Market
Overview of the regional outlook of the Human Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Human Gene Therapy market size was estimated at USD 5677.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Gene Therapy market.
Global Human Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics
Market Segmentation (by Type)
Non-viral Vectors
Viral Vectors
Market Segmentation (by Application)
Neurological Diseases
Cancer
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Gene Therapy Market
Overview of the regional outlook of the Human Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Gene Therapy
1.2 Key Market Segments
1.2.1 Human Gene Therapy Segment by Type
1.2.2 Human Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Human Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Gene Therapy Product Life Cycle
3.3 Global Human Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Human Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Gene Therapy Market Competitive Situation and Trends
3.8.1 Human Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Human Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 HUMAN GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Human Gene Therapy Market Size by Type (2020-2025)
6.4 Global Human Gene Therapy Price by Type (2020-2025)
7 HUMAN GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Human Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Human Gene Therapy Sales Growth Rate by Application (2020-2025)
8 HUMAN GENE THERAPY MARKET SALES BY REGION
8.1 Global Human Gene Therapy Sales by Region
8.1.1 Global Human Gene Therapy Sales by Region
8.1.2 Global Human Gene Therapy Sales Market Share by Region
8.2 Global Human Gene Therapy Market Size by Region
8.2.1 Global Human Gene Therapy Market Size by Region
8.2.2 Global Human Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Human Gene Therapy Sales by Country
8.3.2 North America Human Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Gene Therapy Sales by Country
8.4.2 Europe Human Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Gene Therapy Sales by Region
8.5.2 Asia Pacific Human Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Gene Therapy Sales by Country
8.6.2 South America Human Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Gene Therapy Sales by Region
8.7.2 Middle East and Africa Human Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Human Gene Therapy by Region(2020-2025)
9.2 Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Gene Therapy Production
9.4.1 North America Human Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Gene Therapy Production
9.5.1 Europe Human Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Gene Therapy Production (2020-2025)
9.6.1 Japan Human Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Gene Therapy Production (2020-2025)
9.7.1 China Human Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Human Gene Therapy Product Overview
10.1.3 Biogen Human Gene Therapy Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Sarepta Therapeutics
10.2.1 Sarepta Therapeutics Basic Information
10.2.2 Sarepta Therapeutics Human Gene Therapy Product Overview
10.2.3 Sarepta Therapeutics Human Gene Therapy Product Market Performance
10.2.4 Sarepta Therapeutics Business Overview
10.2.5 Sarepta Therapeutics SWOT Analysis
10.2.6 Sarepta Therapeutics Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Human Gene Therapy Product Overview
10.3.3 Gilead Sciences Human Gene Therapy Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 Amgen
10.4.1 Amgen Basic Information
10.4.2 Amgen Human Gene Therapy Product Overview
10.4.3 Amgen Human Gene Therapy Product Market Performance
10.4.4 Amgen Business Overview
10.4.5 Amgen Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis Human Gene Therapy Product Overview
10.5.3 Novartis Human Gene Therapy Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Orchard Therapeutics
10.6.1 Orchard Therapeutics Basic Information
10.6.2 Orchard Therapeutics Human Gene Therapy Product Overview
10.6.3 Orchard Therapeutics Human Gene Therapy Product Market Performance
10.6.4 Orchard Therapeutics Business Overview
10.6.5 Orchard Therapeutics Recent Developments
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Basic Information
10.7.2 Spark Therapeutics Human Gene Therapy Product Overview
10.7.3 Spark Therapeutics Human Gene Therapy Product Market Performance
10.7.4 Spark Therapeutics Business Overview
10.7.5 Spark Therapeutics Recent Developments
10.8 Agc Biologics
10.8.1 Agc Biologics Basic Information
10.8.2 Agc Biologics Human Gene Therapy Product Overview
10.8.3 Agc Biologics Human Gene Therapy Product Market Performance
10.8.4 Agc Biologics Business Overview
10.8.5 Agc Biologics Recent Developments
10.9 Anges
10.9.1 Anges Basic Information
10.9.2 Anges Human Gene Therapy Product Overview
10.9.3 Anges Human Gene Therapy Product Market Performance
10.9.4 Anges Business Overview
10.9.5 Anges Recent Developments
10.10 Bluebird Bio
10.10.1 Bluebird Bio Basic Information
10.10.2 Bluebird Bio Human Gene Therapy Product Overview
10.10.3 Bluebird Bio Human Gene Therapy Product Market Performance
10.10.4 Bluebird Bio Business Overview
10.10.5 Bluebird Bio Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Basic Information
10.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Overview
10.11.3 Jazz Pharmaceuticals Human Gene Therapy Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 Dynavax Technologies
10.12.1 Dynavax Technologies Basic Information
10.12.2 Dynavax Technologies Human Gene Therapy Product Overview
10.12.3 Dynavax Technologies Human Gene Therapy Product Market Performance
10.12.4 Dynavax Technologies Business Overview
10.12.5 Dynavax Technologies Recent Developments
10.13 Human Stem Cells Institute
10.13.1 Human Stem Cells Institute Basic Information
10.13.2 Human Stem Cells Institute Human Gene Therapy Product Overview
10.13.3 Human Stem Cells Institute Human Gene Therapy Product Market Performance
10.13.4 Human Stem Cells Institute Business Overview
10.13.5 Human Stem Cells Institute Recent Developments
10.14 Sibiono Genetech
10.14.1 Sibiono Genetech Basic Information
10.14.2 Sibiono Genetech Human Gene Therapy Product Overview
10.14.3 Sibiono Genetech Human Gene Therapy Product Market Performance
10.14.4 Sibiono Genetech Business Overview
10.14.5 Sibiono Genetech Recent Developments
10.15 Shanghai Sunway Biotech
10.15.1 Shanghai Sunway Biotech Basic Information
10.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Overview
10.15.3 Shanghai Sunway Biotech Human Gene Therapy Product Market Performance
10.15.4 Shanghai Sunway Biotech Business Overview
10.15.5 Shanghai Sunway Biotech Recent Developments
10.16 Uniqure N.V.
10.16.1 Uniqure N.V. Basic Information
10.16.2 Uniqure N.V. Human Gene Therapy Product Overview
10.16.3 Uniqure N.V. Human Gene Therapy Product Market Performance
10.16.4 Uniqure N.V. Business Overview
10.16.5 Uniqure N.V. Recent Developments
10.17 Gensight Biologics S.A.
10.17.1 Gensight Biologics S.A. Basic Information
10.17.2 Gensight Biologics S.A. Human Gene Therapy Product Overview
10.17.3 Gensight Biologics S.A. Human Gene Therapy Product Market Performance
10.17.4 Gensight Biologics S.A. Business Overview
10.17.5 Gensight Biologics S.A. Recent Developments
10.18 Celgene Corporation
10.18.1 Celgene Corporation Basic Information
10.18.2 Celgene Corporation Human Gene Therapy Product Overview
10.18.3 Celgene Corporation Human Gene Therapy Product Market Performance
10.18.4 Celgene Corporation Business Overview
10.18.5 Celgene Corporation Recent Developments
10.19 Cellectis
10.19.1 Cellectis Basic Information
10.19.2 Cellectis Human Gene Therapy Product Overview
10.19.3 Cellectis Human Gene Therapy Product Market Performance
10.19.4 Cellectis Business Overview
10.19.5 Cellectis Recent Developments
10.20 Sangamo Therapeutics
10.20.1 Sangamo Therapeutics Basic Information
10.20.2 Sangamo Therapeutics Human Gene Therapy Product Overview
10.20.3 Sangamo Therapeutics Human Gene Therapy Product Market Performance
10.20.4 Sangamo Therapeutics Business Overview
10.20.5 Sangamo Therapeutics Recent Developments
10.21 Mustang Bio
10.21.1 Mustang Bio Basic Information
10.21.2 Mustang Bio Human Gene Therapy Product Overview
10.21.3 Mustang Bio Human Gene Therapy Product Market Performance
10.21.4 Mustang Bio Business Overview
10.21.5 Mustang Bio Recent Developments
10.22 AGTC
10.22.1 AGTC Basic Information
10.22.2 AGTC Human Gene Therapy Product Overview
10.22.3 AGTC Human Gene Therapy Product Market Performance
10.22.4 AGTC Business Overview
10.22.5 AGTC Recent Developments
10.23 Poseida Therapeutics
10.23.1 Poseida Therapeutics Basic Information
10.23.2 Poseida Therapeutics Human Gene Therapy Product Overview
10.23.3 Poseida Therapeutics Human Gene Therapy Product Market Performance
10.23.4 Poseida Therapeutics Business Overview
10.23.5 Poseida Therapeutics Recent Developments
11 HUMAN GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Human Gene Therapy Market Size Forecast
11.2 Global Human Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Human Gene Therapy Market Size Forecast by Region
11.2.4 South America Human Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Human Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Human Gene Therapy by Type (2026-2035)
12.1.2 Global Human Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Human Gene Therapy by Type (2026-2035)
12.2 Global Human Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Human Gene Therapy Sales (K MT) Forecast by Application
12.2.2 Global Human Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Gene Therapy
1.2 Key Market Segments
1.2.1 Human Gene Therapy Segment by Type
1.2.2 Human Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Human Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Gene Therapy Product Life Cycle
3.3 Global Human Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Human Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Gene Therapy Market Competitive Situation and Trends
3.8.1 Human Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Human Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 HUMAN GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Human Gene Therapy Market Size by Type (2020-2025)
6.4 Global Human Gene Therapy Price by Type (2020-2025)
7 HUMAN GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Human Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Human Gene Therapy Sales Growth Rate by Application (2020-2025)
8 HUMAN GENE THERAPY MARKET SALES BY REGION
8.1 Global Human Gene Therapy Sales by Region
8.1.1 Global Human Gene Therapy Sales by Region
8.1.2 Global Human Gene Therapy Sales Market Share by Region
8.2 Global Human Gene Therapy Market Size by Region
8.2.1 Global Human Gene Therapy Market Size by Region
8.2.2 Global Human Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Human Gene Therapy Sales by Country
8.3.2 North America Human Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Gene Therapy Sales by Country
8.4.2 Europe Human Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Gene Therapy Sales by Region
8.5.2 Asia Pacific Human Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Gene Therapy Sales by Country
8.6.2 South America Human Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Gene Therapy Sales by Region
8.7.2 Middle East and Africa Human Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Human Gene Therapy by Region(2020-2025)
9.2 Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Gene Therapy Production
9.4.1 North America Human Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Gene Therapy Production
9.5.1 Europe Human Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Gene Therapy Production (2020-2025)
9.6.1 Japan Human Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Gene Therapy Production (2020-2025)
9.7.1 China Human Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Human Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Human Gene Therapy Product Overview
10.1.3 Biogen Human Gene Therapy Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Sarepta Therapeutics
10.2.1 Sarepta Therapeutics Basic Information
10.2.2 Sarepta Therapeutics Human Gene Therapy Product Overview
10.2.3 Sarepta Therapeutics Human Gene Therapy Product Market Performance
10.2.4 Sarepta Therapeutics Business Overview
10.2.5 Sarepta Therapeutics SWOT Analysis
10.2.6 Sarepta Therapeutics Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Human Gene Therapy Product Overview
10.3.3 Gilead Sciences Human Gene Therapy Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 Amgen
10.4.1 Amgen Basic Information
10.4.2 Amgen Human Gene Therapy Product Overview
10.4.3 Amgen Human Gene Therapy Product Market Performance
10.4.4 Amgen Business Overview
10.4.5 Amgen Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis Human Gene Therapy Product Overview
10.5.3 Novartis Human Gene Therapy Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Orchard Therapeutics
10.6.1 Orchard Therapeutics Basic Information
10.6.2 Orchard Therapeutics Human Gene Therapy Product Overview
10.6.3 Orchard Therapeutics Human Gene Therapy Product Market Performance
10.6.4 Orchard Therapeutics Business Overview
10.6.5 Orchard Therapeutics Recent Developments
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Basic Information
10.7.2 Spark Therapeutics Human Gene Therapy Product Overview
10.7.3 Spark Therapeutics Human Gene Therapy Product Market Performance
10.7.4 Spark Therapeutics Business Overview
10.7.5 Spark Therapeutics Recent Developments
10.8 Agc Biologics
10.8.1 Agc Biologics Basic Information
10.8.2 Agc Biologics Human Gene Therapy Product Overview
10.8.3 Agc Biologics Human Gene Therapy Product Market Performance
10.8.4 Agc Biologics Business Overview
10.8.5 Agc Biologics Recent Developments
10.9 Anges
10.9.1 Anges Basic Information
10.9.2 Anges Human Gene Therapy Product Overview
10.9.3 Anges Human Gene Therapy Product Market Performance
10.9.4 Anges Business Overview
10.9.5 Anges Recent Developments
10.10 Bluebird Bio
10.10.1 Bluebird Bio Basic Information
10.10.2 Bluebird Bio Human Gene Therapy Product Overview
10.10.3 Bluebird Bio Human Gene Therapy Product Market Performance
10.10.4 Bluebird Bio Business Overview
10.10.5 Bluebird Bio Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Basic Information
10.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Overview
10.11.3 Jazz Pharmaceuticals Human Gene Therapy Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 Dynavax Technologies
10.12.1 Dynavax Technologies Basic Information
10.12.2 Dynavax Technologies Human Gene Therapy Product Overview
10.12.3 Dynavax Technologies Human Gene Therapy Product Market Performance
10.12.4 Dynavax Technologies Business Overview
10.12.5 Dynavax Technologies Recent Developments
10.13 Human Stem Cells Institute
10.13.1 Human Stem Cells Institute Basic Information
10.13.2 Human Stem Cells Institute Human Gene Therapy Product Overview
10.13.3 Human Stem Cells Institute Human Gene Therapy Product Market Performance
10.13.4 Human Stem Cells Institute Business Overview
10.13.5 Human Stem Cells Institute Recent Developments
10.14 Sibiono Genetech
10.14.1 Sibiono Genetech Basic Information
10.14.2 Sibiono Genetech Human Gene Therapy Product Overview
10.14.3 Sibiono Genetech Human Gene Therapy Product Market Performance
10.14.4 Sibiono Genetech Business Overview
10.14.5 Sibiono Genetech Recent Developments
10.15 Shanghai Sunway Biotech
10.15.1 Shanghai Sunway Biotech Basic Information
10.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Overview
10.15.3 Shanghai Sunway Biotech Human Gene Therapy Product Market Performance
10.15.4 Shanghai Sunway Biotech Business Overview
10.15.5 Shanghai Sunway Biotech Recent Developments
10.16 Uniqure N.V.
10.16.1 Uniqure N.V. Basic Information
10.16.2 Uniqure N.V. Human Gene Therapy Product Overview
10.16.3 Uniqure N.V. Human Gene Therapy Product Market Performance
10.16.4 Uniqure N.V. Business Overview
10.16.5 Uniqure N.V. Recent Developments
10.17 Gensight Biologics S.A.
10.17.1 Gensight Biologics S.A. Basic Information
10.17.2 Gensight Biologics S.A. Human Gene Therapy Product Overview
10.17.3 Gensight Biologics S.A. Human Gene Therapy Product Market Performance
10.17.4 Gensight Biologics S.A. Business Overview
10.17.5 Gensight Biologics S.A. Recent Developments
10.18 Celgene Corporation
10.18.1 Celgene Corporation Basic Information
10.18.2 Celgene Corporation Human Gene Therapy Product Overview
10.18.3 Celgene Corporation Human Gene Therapy Product Market Performance
10.18.4 Celgene Corporation Business Overview
10.18.5 Celgene Corporation Recent Developments
10.19 Cellectis
10.19.1 Cellectis Basic Information
10.19.2 Cellectis Human Gene Therapy Product Overview
10.19.3 Cellectis Human Gene Therapy Product Market Performance
10.19.4 Cellectis Business Overview
10.19.5 Cellectis Recent Developments
10.20 Sangamo Therapeutics
10.20.1 Sangamo Therapeutics Basic Information
10.20.2 Sangamo Therapeutics Human Gene Therapy Product Overview
10.20.3 Sangamo Therapeutics Human Gene Therapy Product Market Performance
10.20.4 Sangamo Therapeutics Business Overview
10.20.5 Sangamo Therapeutics Recent Developments
10.21 Mustang Bio
10.21.1 Mustang Bio Basic Information
10.21.2 Mustang Bio Human Gene Therapy Product Overview
10.21.3 Mustang Bio Human Gene Therapy Product Market Performance
10.21.4 Mustang Bio Business Overview
10.21.5 Mustang Bio Recent Developments
10.22 AGTC
10.22.1 AGTC Basic Information
10.22.2 AGTC Human Gene Therapy Product Overview
10.22.3 AGTC Human Gene Therapy Product Market Performance
10.22.4 AGTC Business Overview
10.22.5 AGTC Recent Developments
10.23 Poseida Therapeutics
10.23.1 Poseida Therapeutics Basic Information
10.23.2 Poseida Therapeutics Human Gene Therapy Product Overview
10.23.3 Poseida Therapeutics Human Gene Therapy Product Market Performance
10.23.4 Poseida Therapeutics Business Overview
10.23.5 Poseida Therapeutics Recent Developments
11 HUMAN GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Human Gene Therapy Market Size Forecast
11.2 Global Human Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Human Gene Therapy Market Size Forecast by Region
11.2.4 South America Human Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Human Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Human Gene Therapy by Type (2026-2035)
12.1.2 Global Human Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Human Gene Therapy by Type (2026-2035)
12.2 Global Human Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Human Gene Therapy Sales (K MT) Forecast by Application
12.2.2 Global Human Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Gene Therapy Market Size by Type (M USD)
Table 4. Global Human Gene Therapy Market Size by Application
Table 5. Human Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Human Gene Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2025)
Table 11. Global Market Human Gene Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Human Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Human Gene Therapy Sales by Type (K MT)
Table 27. Global Human Gene Therapy Market Size by Type (M USD)
Table 28. Global Human Gene Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Human Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Human Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Human Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Human Gene Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Human Gene Therapy Sales (K MT) by Application
Table 34. Global Human Gene Therapy Market Size by Application
Table 35. Global Human Gene Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Human Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Human Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Human Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Human Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Human Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Human Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Human Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Human Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Human Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Human Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Human Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Human Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Human Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Human Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Human Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Human Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Human Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Human Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Human Gene Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Human Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Biogen Basic Information
Table 63. Biogen Human Gene Therapy Product Overview
Table 64. Biogen Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Biogen Business Overview
Table 66. Biogen SWOT Analysis
Table 67. Biogen Recent Developments
Table 68. Sarepta Therapeutics Basic Information
Table 69. Sarepta Therapeutics Human Gene Therapy Product Overview
Table 70. Sarepta Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sarepta Therapeutics Business Overview
Table 72. Sarepta Therapeutics SWOT Analysis
Table 73. Sarepta Therapeutics Recent Developments
Table 74. Gilead Sciences Basic Information
Table 75. Gilead Sciences Human Gene Therapy Product Overview
Table 76. Gilead Sciences Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences SWOT Analysis
Table 79. Gilead Sciences Recent Developments
Table 80. Amgen Basic Information
Table 81. Amgen Human Gene Therapy Product Overview
Table 82. Amgen Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Amgen Business Overview
Table 84. Amgen Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis Human Gene Therapy Product Overview
Table 87. Novartis Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Orchard Therapeutics Basic Information
Table 91. Orchard Therapeutics Human Gene Therapy Product Overview
Table 92. Orchard Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Orchard Therapeutics Business Overview
Table 94. Orchard Therapeutics Recent Developments
Table 95. Spark Therapeutics Basic Information
Table 96. Spark Therapeutics Human Gene Therapy Product Overview
Table 97. Spark Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Spark Therapeutics Business Overview
Table 99. Spark Therapeutics Recent Developments
Table 100. Agc Biologics Basic Information
Table 101. Agc Biologics Human Gene Therapy Product Overview
Table 102. Agc Biologics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Agc Biologics Business Overview
Table 104. Agc Biologics Recent Developments
Table 105. Anges Basic Information
Table 106. Anges Human Gene Therapy Product Overview
Table 107. Anges Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Anges Business Overview
Table 109. Anges Recent Developments
Table 110. Bluebird Bio Basic Information
Table 111. Bluebird Bio Human Gene Therapy Product Overview
Table 112. Bluebird Bio Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bluebird Bio Business Overview
Table 114. Bluebird Bio Recent Developments
Table 115. Jazz Pharmaceuticals Basic Information
Table 116. Jazz Pharmaceuticals Human Gene Therapy Product Overview
Table 117. Jazz Pharmaceuticals Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jazz Pharmaceuticals Business Overview
Table 119. Jazz Pharmaceuticals Recent Developments
Table 120. Dynavax Technologies Basic Information
Table 121. Dynavax Technologies Human Gene Therapy Product Overview
Table 122. Dynavax Technologies Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Dynavax Technologies Business Overview
Table 124. Dynavax Technologies Recent Developments
Table 125. Human Stem Cells Institute Basic Information
Table 126. Human Stem Cells Institute Human Gene Therapy Product Overview
Table 127. Human Stem Cells Institute Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Human Stem Cells Institute Business Overview
Table 129. Human Stem Cells Institute Recent Developments
Table 130. Sibiono Genetech Basic Information
Table 131. Sibiono Genetech Human Gene Therapy Product Overview
Table 132. Sibiono Genetech Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Sibiono Genetech Business Overview
Table 134. Sibiono Genetech Recent Developments
Table 135. Shanghai Sunway Biotech Basic Information
Table 136. Shanghai Sunway Biotech Human Gene Therapy Product Overview
Table 137. Shanghai Sunway Biotech Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Shanghai Sunway Biotech Business Overview
Table 139. Shanghai Sunway Biotech Recent Developments
Table 140. Uniqure N.V. Basic Information
Table 141. Uniqure N.V. Human Gene Therapy Product Overview
Table 142. Uniqure N.V. Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Uniqure N.V. Business Overview
Table 144. Uniqure N.V. Recent Developments
Table 145. Gensight Biologics S.A. Basic Information
Table 146. Gensight Biologics S.A. Human Gene Therapy Product Overview
Table 147. Gensight Biologics S.A. Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Gensight Biologics S.A. Business Overview
Table 149. Gensight Biologics S.A. Recent Developments
Table 150. Celgene Corporation Basic Information
Table 151. Celgene Corporation Human Gene Therapy Product Overview
Table 152. Celgene Corporation Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Celgene Corporation Business Overview
Table 154. Celgene Corporation Recent Developments
Table 155. Cellectis Basic Information
Table 156. Cellectis Human Gene Therapy Product Overview
Table 157. Cellectis Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Cellectis Business Overview
Table 159. Cellectis Recent Developments
Table 160. Sangamo Therapeutics Basic Information
Table 161. Sangamo Therapeutics Human Gene Therapy Product Overview
Table 162. Sangamo Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Sangamo Therapeutics Business Overview
Table 164. Sangamo Therapeutics Recent Developments
Table 165. Mustang Bio Basic Information
Table 166. Mustang Bio Human Gene Therapy Product Overview
Table 167. Mustang Bio Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Mustang Bio Business Overview
Table 169. Mustang Bio Recent Developments
Table 170. AGTC Basic Information
Table 171. AGTC Human Gene Therapy Product Overview
Table 172. AGTC Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. AGTC Business Overview
Table 174. AGTC Recent Developments
Table 175. Poseida Therapeutics Basic Information
Table 176. Poseida Therapeutics Human Gene Therapy Product Overview
Table 177. Poseida Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Poseida Therapeutics Business Overview
Table 179. Poseida Therapeutics Recent Developments
Table 180. Global Human Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 181. Global Human Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Human Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 183. North America Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Human Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 185. Europe Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Human Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 187. Asia Pacific Human Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Human Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 189. South America Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Human Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Human Gene Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 193. Global Human Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Human Gene Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 195. Global Human Gene Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 196. Global Human Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Gene Therapy Market Size by Type (M USD)
Table 4. Global Human Gene Therapy Market Size by Application
Table 5. Human Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Human Gene Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2025)
Table 11. Global Market Human Gene Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Human Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Human Gene Therapy Sales by Type (K MT)
Table 27. Global Human Gene Therapy Market Size by Type (M USD)
Table 28. Global Human Gene Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Human Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Human Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Human Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Human Gene Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Human Gene Therapy Sales (K MT) by Application
Table 34. Global Human Gene Therapy Market Size by Application
Table 35. Global Human Gene Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Human Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Human Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Human Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Human Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Human Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Human Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Human Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Human Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Human Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Human Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Human Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Human Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Human Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Human Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Human Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Human Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Human Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Human Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Human Gene Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Human Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Human Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Human Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Biogen Basic Information
Table 63. Biogen Human Gene Therapy Product Overview
Table 64. Biogen Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Biogen Business Overview
Table 66. Biogen SWOT Analysis
Table 67. Biogen Recent Developments
Table 68. Sarepta Therapeutics Basic Information
Table 69. Sarepta Therapeutics Human Gene Therapy Product Overview
Table 70. Sarepta Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sarepta Therapeutics Business Overview
Table 72. Sarepta Therapeutics SWOT Analysis
Table 73. Sarepta Therapeutics Recent Developments
Table 74. Gilead Sciences Basic Information
Table 75. Gilead Sciences Human Gene Therapy Product Overview
Table 76. Gilead Sciences Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences SWOT Analysis
Table 79. Gilead Sciences Recent Developments
Table 80. Amgen Basic Information
Table 81. Amgen Human Gene Therapy Product Overview
Table 82. Amgen Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Amgen Business Overview
Table 84. Amgen Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis Human Gene Therapy Product Overview
Table 87. Novartis Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Orchard Therapeutics Basic Information
Table 91. Orchard Therapeutics Human Gene Therapy Product Overview
Table 92. Orchard Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Orchard Therapeutics Business Overview
Table 94. Orchard Therapeutics Recent Developments
Table 95. Spark Therapeutics Basic Information
Table 96. Spark Therapeutics Human Gene Therapy Product Overview
Table 97. Spark Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Spark Therapeutics Business Overview
Table 99. Spark Therapeutics Recent Developments
Table 100. Agc Biologics Basic Information
Table 101. Agc Biologics Human Gene Therapy Product Overview
Table 102. Agc Biologics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Agc Biologics Business Overview
Table 104. Agc Biologics Recent Developments
Table 105. Anges Basic Information
Table 106. Anges Human Gene Therapy Product Overview
Table 107. Anges Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Anges Business Overview
Table 109. Anges Recent Developments
Table 110. Bluebird Bio Basic Information
Table 111. Bluebird Bio Human Gene Therapy Product Overview
Table 112. Bluebird Bio Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bluebird Bio Business Overview
Table 114. Bluebird Bio Recent Developments
Table 115. Jazz Pharmaceuticals Basic Information
Table 116. Jazz Pharmaceuticals Human Gene Therapy Product Overview
Table 117. Jazz Pharmaceuticals Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jazz Pharmaceuticals Business Overview
Table 119. Jazz Pharmaceuticals Recent Developments
Table 120. Dynavax Technologies Basic Information
Table 121. Dynavax Technologies Human Gene Therapy Product Overview
Table 122. Dynavax Technologies Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Dynavax Technologies Business Overview
Table 124. Dynavax Technologies Recent Developments
Table 125. Human Stem Cells Institute Basic Information
Table 126. Human Stem Cells Institute Human Gene Therapy Product Overview
Table 127. Human Stem Cells Institute Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Human Stem Cells Institute Business Overview
Table 129. Human Stem Cells Institute Recent Developments
Table 130. Sibiono Genetech Basic Information
Table 131. Sibiono Genetech Human Gene Therapy Product Overview
Table 132. Sibiono Genetech Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Sibiono Genetech Business Overview
Table 134. Sibiono Genetech Recent Developments
Table 135. Shanghai Sunway Biotech Basic Information
Table 136. Shanghai Sunway Biotech Human Gene Therapy Product Overview
Table 137. Shanghai Sunway Biotech Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Shanghai Sunway Biotech Business Overview
Table 139. Shanghai Sunway Biotech Recent Developments
Table 140. Uniqure N.V. Basic Information
Table 141. Uniqure N.V. Human Gene Therapy Product Overview
Table 142. Uniqure N.V. Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Uniqure N.V. Business Overview
Table 144. Uniqure N.V. Recent Developments
Table 145. Gensight Biologics S.A. Basic Information
Table 146. Gensight Biologics S.A. Human Gene Therapy Product Overview
Table 147. Gensight Biologics S.A. Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Gensight Biologics S.A. Business Overview
Table 149. Gensight Biologics S.A. Recent Developments
Table 150. Celgene Corporation Basic Information
Table 151. Celgene Corporation Human Gene Therapy Product Overview
Table 152. Celgene Corporation Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Celgene Corporation Business Overview
Table 154. Celgene Corporation Recent Developments
Table 155. Cellectis Basic Information
Table 156. Cellectis Human Gene Therapy Product Overview
Table 157. Cellectis Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Cellectis Business Overview
Table 159. Cellectis Recent Developments
Table 160. Sangamo Therapeutics Basic Information
Table 161. Sangamo Therapeutics Human Gene Therapy Product Overview
Table 162. Sangamo Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Sangamo Therapeutics Business Overview
Table 164. Sangamo Therapeutics Recent Developments
Table 165. Mustang Bio Basic Information
Table 166. Mustang Bio Human Gene Therapy Product Overview
Table 167. Mustang Bio Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Mustang Bio Business Overview
Table 169. Mustang Bio Recent Developments
Table 170. AGTC Basic Information
Table 171. AGTC Human Gene Therapy Product Overview
Table 172. AGTC Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. AGTC Business Overview
Table 174. AGTC Recent Developments
Table 175. Poseida Therapeutics Basic Information
Table 176. Poseida Therapeutics Human Gene Therapy Product Overview
Table 177. Poseida Therapeutics Human Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Poseida Therapeutics Business Overview
Table 179. Poseida Therapeutics Recent Developments
Table 180. Global Human Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 181. Global Human Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Human Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 183. North America Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Human Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 185. Europe Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Human Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 187. Asia Pacific Human Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Human Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 189. South America Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Human Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Human Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Human Gene Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 193. Global Human Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Human Gene Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 195. Global Human Gene Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 196. Global Human Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Human Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Human Gene Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Gene Therapy Product Life Cycle
Figure 13. Human Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Human Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Human Gene Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Human Gene Therapy
Figure 19. Global Human Gene Therapy Market PEST Analysis
Figure 20. Global Human Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Human Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Human Gene Therapy by Type in 2025
Figure 29. Market Share of Human Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Human Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Gene Therapy Market Share by Application
Figure 33. Global Human Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Human Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Human Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Human Gene Therapy Market Share by Application in 2025
Figure 37. Global Human Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Human Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Gene Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Gene Therapy Market Size by Country in 2024
Figure 55. Germany Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Gene Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Gene Therapy Market Size by Region in 2024
Figure 68. China Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Gene Therapy Sales and Growth Rate (K MT)
Figure 79. South America Human Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Human Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Human Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Gene Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Gene Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Human Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Human Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Human Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Human Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Human Gene Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Human Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Human Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Human Gene Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Gene Therapy Product Life Cycle
Figure 13. Human Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Human Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Human Gene Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Human Gene Therapy
Figure 19. Global Human Gene Therapy Market PEST Analysis
Figure 20. Global Human Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Human Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Human Gene Therapy by Type in 2025
Figure 29. Market Share of Human Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Human Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Gene Therapy Market Share by Application
Figure 33. Global Human Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Human Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Human Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Human Gene Therapy Market Share by Application in 2025
Figure 37. Global Human Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Human Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Gene Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Gene Therapy Market Size by Country in 2024
Figure 55. Germany Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Gene Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Gene Therapy Market Size by Region in 2024
Figure 68. China Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Gene Therapy Sales and Growth Rate (K MT)
Figure 79. South America Human Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Human Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Human Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Gene Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Gene Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Human Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Human Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Human Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Human Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Human Gene Therapy Market Share Forecast by Application (2026-2035)
